Polymorphisms in the CD6-ALCAM axis may modulate psoriasis risk and outcomes
Marta Wagner(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Monika Jasek(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Maciej Sobczyński(University of Wrocław), Łukasz Matusiak(Wrocław University of Science and Technology), Andrzej Wiśniewski(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Piotr Kuśnierczyk(Immungenetics (Germany))
Cited by 3
Related Papers
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
|Journal of the European Academy of Dermatology and Venereology|2015|1.1k
Hidradenitis suppurativa
|Nature Reviews Disease Primers|2020|567
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
|British Journal of Dermatology|2017|467
Diagnostic delay in hidradenitis suppurativa is a global problem
|British Journal of Dermatology|2015|392
Psychophysical Aspects of Hidradenitis Suppurativa
|Acta Dermato Venereologica|2010|302